BioSpace

Earlier this month, Kezar Life Sciences announced that the mid-stage test of zetomipzomib in lupus nephritis had been placed on an FDA clinical hold. Now, that program is being terminated. #FDA #lupus #pharma #biospace https://hubs.li/Q02TR0TG0

The biopharma layoffs continue, with Sage Therapeutics announcing it will let go 33% of its workforce. Get the details on this and other employee cuts in our regularly updated layoff tracker. #biopharma #layoffs #biospace https://hubs.ly/Q02TQGGN0

As part of a strategic reorganization intended in part to support the ongoing launch of its postpartum depression drug, Sage Therapeutics is cutting more than 165 employees. #layoffs #biotech #biospace https://hubs.ly/Q02TQF-G0

In a tough labor market where layoffs continue, some are considering—or even moving—from industry to academia, according to a BioSpace poll. A career coach, scientist and general practitioner turned research coordinator share their thoughts. #careerpath #layoffs #biospace https://hubs.ly/Q02TQF-y0

People with advanced Parkinson’s disease have a new treatment option Thursday as the FDA greenlit AbbVie's Vyalev as “the first and only subcutaneous 24-hour infusion of levodopa-based therapy for the treatment of motor fluctuations” in this patient population. #parkinsons #disease #FDA #biospace https://hubs.li/Q02TPzwN0

Real-world evidence show that GSK and ViiV Healthcare's long-acting pre-exposure prophylaxis Apretude can prevent nearly all HIV infections, while rival Gilead Sciences is moving quickly toward an approval for a twice-yearly option. #HIV #pharma #biospace https://hubs.li/Q02TPjZ20

The mpox vaccine induced an antibody response in adolescents aged 12 to 17 years that matched that in adults, suggesting the shot can be used to protect the highly susceptible group. #mpox #pharma #vaccines #biospace https://hubs.li/Q02TPsF70

Are you eager to enter the exciting world of biotechnology? Whether you’re considering the next steps after your undergrad or master’s program or feeling overwhelmed by the competitive job market, this webinar will provide you with practical strategies and insights to break into the biotech industry with confidence. Learn more and register here: https://hubs.li/Q02SwYR20 #webinar #biotech #careers #careeradvice #biospace

Opdivo showed a 52% progression-free survival advantage over Adcetris in newly diagnosed Hodgkin’s lymphoma, according to a Phase III study that combined either therapy with doxorubicin, vinblastine and dacarbazine. #pharma #biospace https://hubs.li/Q02TP9DT0

Thursday’s agreement with Orano Med is the second in as many months. Sanofi in September made its first foray into the radioligand space with a $110 million licensing deal with Orano Med and Texas biotech RadioMedix. #radiopharma #deal #biospace https://hubs.li/Q02TPgpq0